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Listeria monocytogenes is an opportunistic and intracellular foodborne pathogen that can be deadly in high 
risk populations. During infection in the human body, L. monocytogenes may encounter macrophages, a type 
of white blood cell that is critical in innate immune response both by directly targeting invading pathogens 
and by eliciting adaptive immune responses. During intestinal as well as peripheral infections, both L. 
monocytogenes and macrophages may encounter propionate, a common gut microbiome metabolite. 
Although propionate is shown to have various regulatory and nutritional functions, its effects on infection 
outcome is not well understood. Therefore, the goal of this research is to determine how the exposure to 
propionate by L. monocytogenes and macrophages may affect subsequent infection outcomes. Specifically, 
the effects of propionate on phagocytic activity of macrophages will be quantified by measuring macrophage 
uptake of fluorescently labeled L. monocytogenes after exposure to different propionate concentrations. 
Additionally, the effects of propionate on the bactericidal activities inside macrophage phagosomes will be 
determined by quantifying the number of intracellular L. monocytogenes mutant deficient in listeriolysin O 
which remains inside phagosomes instead of escaping into the cytoplasm. The findings of this research will 
provide more information on how the immune response is regulated by propionate and offer a mechanistic 
insight into the vast role of the gut microbiome. 
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The goal of this research project is to establish the effects of propionate on the 
antimicrobial functions of macrophages against the foodborne, intracellular pathogen 
Listeria monocytogenes. A better understanding of how environmental factors impact 
infection outcome is needed so that we can optimize clinical treatment of infectious 
diseases. Currently, antibiotics are the default method of treating bacterial infections. 
However, overuse of antibiotics has led to antibiotic resistance as a rising issue that limits 
treatment options for many pathogens. Every year, 2 million people in the United States 
are infected with  bacteria, and 23,000 die as a result.1 The cause for the rise of antibiotic 
resistance is multi-faceted. One cause involves the insufficient healthcare policies currently 
in place for antibiotic subscription. Guidelines for antibiotic subscriptions often are not 
specific for all possible scenarios. Physicians must evaluate a patient's severity and 
duration of symptoms, prior history of infection, and susceptibility to infection in order to 
select an appropriate prescription. This time-consuming process is not realistic or feasible 
when antibiotic treatments are immediately needed. The CDC has stated that 20%-50% of 
all prescribed antibiotics in acute care hospitals are “inappropriate, or unnecessary”.2 This 
data reveals that better and more readily available infection criteria are necessary to help 
clinicians make more appropriate prescribing decisions. To maximize and enhance 
treatment options for bacterial infections, it is important to understand the involvement of 
environmental factors during pathogenesis.  
Listeria monocytogenes is an intracellular, gram-positive pathogen that can grow 
inside macrophages. As an intracellular pathogen, L. monocytogenes is shielded from many 
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antibiotics while growing within macrophage cells. As a foodborne pathogen, L. 
monocytogenes infects the intestine cell lining and spreads to peripheral organs. In healthy 
individuals, the pathogen typically causes symptoms similar to food poisoning, which 
generally do not develop into a serious infection. However, in pregnant women and people 
with compromised immune systems, L. monocytogenes infections can become septic and 
spread to the nervous system or bloodstream.3 This pathogen can be deadly for these 
susceptible populations. The CDC estimates that each year, approximately 1,600 people in 
the United States become sick from L. monocytogenes, and about 260 of those people 
die.4Although L. monocytogenes infections are relatively rare, they can be difficult to treat 
and life threatening.  
While a L. monocytogenes infection does not usually necessitate medical attention, 
there are specific guidelines for treating it. When an individual presents symptoms of food 
poisoning during L. monocytogenes infection, they are likely to be tested for different 
infections through various blood and fluid samples. In the meantime, they may be 
prescribed antibiotics empirically such as ampicillin or amoxicillin if deemed necessary. If 
laboratory results indicate that the pathogen is L. monocytogenes, ampicillin and 
gentamicin are the first line of antibiotics prescribed.5 L. monocytogenes is not typically 
regarded as an antibiotic resistant pathogen. In a study conducted on human isolates from 
France, it was found that only 1.27% of L. monocytogenes were resistant to a clinically 
relevant antibiotic.6 However, resistance to tetracyclines and fluoroquinolones was 
reported, raising the concern for the emergence of resistance to these types of antibiotics. 
It is important to proactively address the possibility of limited antibiotic treatment options 
before it occurs.  
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Interactions between macrophages and L. monocytogenes 
Macrophages are white blood cells that are involved in our innate immune defense 
mechanisms. They can detect when a pathogen is present, send a stress signal to nearby 
cells, and engulf the pathogen through a mechanism called phagocytosis. Phagocytosis is 
the primary mechanism by which macrophages directly kill foreign pathogens. The first 
step in this process is recognition of pathogen associated molecular patterns (PAMPs) by 
Toll-like receptors (TLRs) and some G-protein coupled receptors located on the 
macrophage membrane.7 The next step in phagocytosis is polymerization and 
depolymerization of the actin skeleton to extend around the pathogen. The actin skeleton 
is then eliminated at the ends of the two pseudopodia so that they connect and bring the 
particle into the macrophage within a vesicle known as the phagosome.7 Lastly, the 
phagosome fuses with lysosome, forming phagolysosome. Lysosomes contain hydrolytic 
enzymes and antimicrobial molecules, such as nitric oxide, reactive oxygen species, 
proteases, lipases, and antimicrobial peptides.7 Lysosomes are also characterized by a low 
pH, which can become as low as 4.5.7 This acidic pH can be damaging to many pathogens. 
Once the phagosome fuses with lysosome, the pathogen is exposed to these toxic 
conditions and begins to be degraded and excreted as waste. Thus, macrophages play a 
crucial role in the immune response to eliminate pathogens.  
 Another critical function of macrophages is to initiate an elevated immune response 
once a pathogen is detected. This is accomplished through secretion of various cytokines. 
Cytokines such as IL-1 beta and TNF-alpha increase permeability and flow of vascular 
endothelium.8 As a result, the flow of leukocytes from the blood increases, enabling them 
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to reach the site of macrophage activation and help destroy the pathogen. A type of cytokine 
known as a chemokine is also responsible for recruiting leukocytes to the site of infection. 
When macrophages secrete chemokines, the chemokines serve as a gradient of molecules 
that leukocytes can bind to, inducing a form of cell motility known as chemotaxis.8 Overall, 
the systematic effects of an elevated immune response due to macrophages include fever 
and inflammation at the location of infection.  
Similar to other pathogens, L. monocytogenes triggers a pro-inflammatory immune 
response in macrophages. During active invasion by L. monocytogenes, internalin, a 
protein that extends from the bacterial cell wall, interacts with E-cadherins, a type of 
adhesion molecule on the surface of host cells.9 Internalin enables the bacteria to stick to 
the host cell. Once L. monocytogenes enters through an invasive route, it becomes located 
in the cytoplasm where it can begin to grow. However, L. monocytogenes can also enter 
passively by manipulating the phagocytosis process to survive and multiply within 
macrophages. Escape from the phagosome is possible through one of the most significant 
L. monocytogenes virulence factors, Listeriolysin O (LLO). The LLO protein is encoded 
by the hly gene and is a pH-dependent pore forming toxin. The optimal pH for proper LLO 
lysis is about 6.10 As the pH in a phagosome decreases to 6, LLO begins binding to 
cholesterol on the phagosomal membrane. Cholesterol binding subsequently enables LLO 
to enter and oligomerize in the phagosomal membrane until a pore is formed.10 As a result, 
the phagosomes collapse, releasing L. monocytogenes to grow in the cytosol and invade 
neighboring cells. Without a functioning hly gene, however, L. monocytogenes is unable 
to escape the phagosome and grow and is ultimately killed by the host cell inside the 
phagolysosomes.11 Therefore, LLO is a necessary virulence factor for L. monocytogenes 
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survival and growth inside macrophages. The complex interactions between L. 
monocytogenes and macrophages are vast, but escape from the phagosome is a vital 
component of these interactions. The ability of L. monocytogenes to escape from the 
phagosome establishes it as a significant infectious human pathogen. Consequently, this 
research aims to study more specifically how environmental factors may affect the ability 
of L. monocytogenes to escape from the phagosome.  
 
The physiological effects of propionate and other short chain fatty acids 
The environmental factor that this project investigates is the presence of propionate, 
a short chain fatty acid (SCFA) commonly found in the gut. SCFAs, and their interactions 
with the gut microbiota have recently come to the forefront of research since they have 
been shown to be involved in many processes in the body, impacting many aspects of 
human health. Studies have indicated that SCFAs can activate specific receptors on the 
cells in the liver, pancreas, adipose tissue, and brain. One study found that SCFAs have an 
impact on diabetes by regulating glucose homeostasis through interactions with the 
pancreatic cells.12 Another study found correlations between the concentrations of SCFAs 
present in colonic bile and risk for cancer.13 Propionate has even been shown to have 
impacts on the behaviors of mice, causing reduced social interaction, increased anxiety‐
related behavior, and hypoactivity.14 SCFAs are being studied to determine a wide range 
of physiological and psychological effects, and have been shown to interact with the body 
in numerous ways. 
SCFAs are carboxylic acids containing two to six carbons. Bacteria in the gut 
produce short chain fatty acids as a byproduct of the metabolism of high-fiber foods. It is 
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estimated that 500-600 mmol of SCFAs are produced each day by gut bacteria.15 The three 
dominant SCFAs produced by bacteria in the gut are acetate, butyrate, and propionate. In 
the colon, these are found in concentrations of approximately 60% acetate, 25% propionate, 
and 15% butyrate.16 Although they originate in the gut, SCFAs can cross endothelial layers 
and be found in the bloodstream and other tissues at a lower concentration.15  
It is likely that macrophages come into contact with propionate within the gut, 
blood stream, and tissues surrounding the gut. Although it is difficult to identify the exact 
concentration of propionate in the gut, there is an estimated concentration of 20 mM of 
propionate in human fecal samples.15 This definitive presence of propionate in the gut, 
along with the knowledge that macrophages are one of the dominant leukocytes in the gut,17 
suggest that interactions between macrophages and propionate are likely frequent. 
Furthermore, it is possible that macrophages encounter propionate in the bloodstream, 
tissues surrounding the gut, and the blood-brain barrier. Studies have found that SCFAs 
are found at low concentrations near the intestines and can cross the blood-brain barrier.15 
The gut and blood-brain barrier are sites in which macrophages are present at relatively 
high levels. While it is estimated that SCFAs are one thousand times less concentrated in 
peripheral blood,18 this smaller concentration is significant. Considering the known effects 
of propionate on other cells and the likelihood that macrophages encounter propionate, the 
effects of propionate on macrophage activity are important to investigate. 
 Recent research has demonstrated that propionate has exhibited generally anti-
inflammatory effects on macrophages.19,20,21 For example, macrophages that were 
activated using staphylococcal lipoprotein exhibited less nitric oxide production when 
treated with varying concentrations of propionate (0.3, 1, 3 mM) than without any 
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propionate.21 Since nitric oxide has antimicrobial and cytotoxic properties, a reduced nitric 
oxide concentration due to propionate indicates a decrease in the response to infection. 
Furthermore, the study indicated that propionate inhibited activation of the NF-kB 
pathway, and STAT-1 phosphorylation.21 Both of these processes are critical steps in the 
activation of the pro-inflammatory response, including NOS2 expression. In addition to 
these findings, it has been determined that nitric oxide can increase the cell to cell spread 
of L. monocytogenes in TLR-activated macrophages. More specifically, nitric oxide delays 
fusion of the phagosome and lysosome, allowing L. monocytogenes more time to survive 
and escape from the phagosome.22 Together, these findings indicate that propionate may 
have a significant effect on the interactions between macrophages and L. monocytogenes. 
While the effects of propionate on macrophages have been investigated, the effects of 
propionate on macrophage and L. monocytogenes interactions have yet to be determined.   
 
Specific research goals 
(1) Determine the effect of propionate on general phagocytosis by macrophages. 
The effect of propionate on general phagocytosis of macrophages will be measured 
using a phagocytosis assay kit. This kit utilizes dead, fluorescently labelled E.coli particles 
that can be measured as an indicator of how much E. coli is phagocytized by macrophages. 
The propionate concentrations can be altered to determine the effect with different levels 
of propionate. This will provide information on how macrophages respond to propionate 
in the absence of an infection. 
(2) Determine the effect of propionate on macrophage and L. monocytogenes infection. 
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The effects of propionate during an infection with L. monocytogenes will be 
measured to determine infection outcome. This is completed using a standard gentamicin 
protection assay to count colony forming units and determine the percent survival of                
L. monocytogenes under various environmental conditions and propionate treatments 
before and/or during infections. One environmental condition that will be tested is the 
presence and absence of oxygen. This can be accomplished using aerobically and 
anaerobically grown L. monocytogenes, which will be important to study because there are 
several instances in which macrophages and L. monocytogenes can be exposed to anaerobic 
conditions. For example, L. monocytogenes can be found in low oxygen conditions in food 
packaging. Additionally, macrophages and L. monocytogenes may reside in the digestive 
tract, which has significant changes in oxygen conditions. Thus, oxygen levels will be an 
included variable in this study to simulate the various oxygen conditions that L. 
monocytogenes and macrophages may encounter in a clinical infection.  
(3) Determine the subcellular location of the effect of propionate using an hly mutant of L. 
monocytogenes. 
To determine how propionate mediates its effects, an hly mutant strain of L. 
monocytogenes will be used during a standard gentamicin protection assay. The hly mutant 
cannot produce the LLO protein, which binds to cholesterol on the phagosome membrane 
and causes perforations in the membrane that allow L monocytogenes to escape into the 
cytosol. LLO production is a critical part of L. monocytogenes pathogenesis because 
without escaping the phagosome, L. monocytogenes is degraded by enzymes and cannot 
grow. Therefore, if propionate impacts the survival of L. monocytogenes mutants, then it 
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is likely that propionate has an effect at some molecular pathway that occurs before 
degradation in the phagosome. 
(4) Determine the effect of propionate on phagocytosis of L. monocytogenes using 
fluorescently labelled bacteria. 
Lastly, the effect of propionate on phagocytosis of macrophages will be measured. 
L. monocytogenes will be fluorescently labelled and measured at the end of infection to 
determine how many were phagocytized. Again, oxygen conditions of L. monocytogenes 
cultures will be altered to simulate actual conditions. Additionally, macrophages will be 
activated using LPS and IFN-γ. Phagocytic activity, with and without propionate, will also 
be measured on LLO deficient L. monocytogenes to determine whether the effects on L. 
monocytogenes intracellular survival are due to changes in phagocytic activity. While not 
all variables are used simultaneously in any given experiment, Table 1 summarizes the 
possible variables to be tested throughout these investigations.  
Table 1. Possible treatment options for L. monocytogenes and macrophages with and 
without infection 
Cells Treatments Treatment Options 
Listeria  Oxygen Level  Aerobic or Anaerobic 
 Strain WT or hly mutant 
 Propionate  0 or 25 mM 
Macrophage  Propionate  0, 0.1, or 1 mM 
 Activation  ± IFNγ/LPS 
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Methods 
L. monocytogenes strains and culture conditions 
The bacterial strain used in this research was Listeria monocytogenes strain 10403s, 
including the wild type (WT) and the isogenic hly mutant. The hly mutant contains a clean 
deletion of the hly gene and as a result could not produce the LLO protein. The absence of 
the LLO protein prohibited the hly mutant from escaping the macrophage phagosome. 
Bacteria used in this research were cultured overnight in 2 mL of filter-sterilized brain heart 
infusion (BHI) media. The BHI was filter-sterilized rather than autoclaved so that the effect 
of heat on the media did not create inconsistencies in bacterial growth. Approximately 1-3 
colonies were added to each culture. The aerobic cultures were incubated at 37.0°C and 
shaken at 180 rpm. The anaerobic cultures were also incubated at 37.0°C, but were cultured 
statically in an anaerobic chamber (Coy Laboratory, Type A). The nitrogenous chamber 
contained an atmosphere with an average of 2.5% hydrogen.  
Macrophage and culture conditions 
The macrophages cultured in these experiments were RAW264.7 macrophages 
from murine peritoneal space and purchased from ATCC. They were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM; Corning 10-013-CV) with 10% fetal bovine 
serum (Corning 35-010-CV) and penicillin/streptomycin (BioWhittaker 17-603E). The 
macrophages were incubated in a 5% CO2 incubator at 37.0°C. Macrophages were 
activated by treatment with 1 ng/mL lipopolysaccharide and 10 ng/mL interferon-γ for 18 
hours in a 24 well plate. Each plate contained a total of 6⨉106 macrophages. 
Phagocytosis assay 
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Naive and activated macrophages were treated with or without propionate (0, 0.1 
mM, and 1.0 mM) in a cell culture dish for ~18 hours prior to infection. The cells were 
then seeded in a 96 well plate and incubated for 2 hours. During the macrophage 
incubation, dead fluorescently labelled E. coli particles were prepared from the Vybrant 
Phagocytosis Assay Kit (V-6694). The prepared solution was suspended in 4.5 mL of 
sterile deionized water. After the 2 hour incubation, 100 uL of the fluorescent bioparticles 
were added to each well and the plate was covered and incubated for two hours. Trypan 
blue from the phagocytosis kit was prepared in 4 mL of sterile deionized water during the 
incubation period. After the 2 hour incubation period, the cells were washed with DPBS 
and 100 uL of trypan blue was added to each well after the bioparticles were aspirated. The 
dye was removed after 1 minute and fluorescence was measured at λex=480 nm and 
λem=520 nm. 
CFSE labeling 
Carboxyfluorescein succinimidyl ester (CFSE; Invitrogen™ 65085084) was 
prepared by suspending the purchased sample in 90 uL of DMSO to form a 10 mM 
solution. This solution was diluted and aliquoted into 1 mM solutions, which were stored 
at -20° C, to minimize repeated freeze thawing. One hour prior to infection, L. 
monocytogenes cultures were centrifuged at 10,000 rpm for 3 minutes and then washed 
with PBS. The optical densities of the cultures were measured on a 96-well plate reader at 
600 nm. The volume needed for a MOI of 10 was determined from the OD measurement 
and 300 uL of each culture were aliquoted for labeling. Based on initial trials with the 
CFSE label, it was determined that 1.6x10-7 uL of 1 mM CFSE is sufficient for 1 CFU of 
L. monocytogenes. The volume of CFSE needed to label each culture was calculated based 
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on the OD measurement of each culture and the respective volumes of CFSE were added 
to each 300 uL culture. After 15 minutes, the bacteria were washed twice with PBS. 
Fluorescence was measured on a 96 well plate reader at a peak λex=494 nm and λem= 521 
nm.  
Gentamicin protection assay 
A gentamicin protection assay was used to determine intracellular colony forming 
units (CFU) and percent survival of L. monocytogenes in RAW264.7 macrophages. A total 
of 6x106 macrophages were seeded per 24-well tissue culture plate ~20 hours prior to 
infection. Cells were activated using 1 ng/mL lipopolysaccharide and 10 ng/mL interferon-
γ. After incubating overnight, the DMEM was removed and fresh DMEM, with or without 
1 mM propionate, was added. The cells were incubated for three hours and the overnight 
L. monocytogenes cultures were prepared and labeled with CFSE. The bacteria were then 
normalized by diluting proportional volumes in DMEM so that there was a multiplicity of 
infection of 10. After the three hour propionate treatment, the media from the wells were 
removed and 500 uL of the normalized labeled L. monocytogenes suspensions were added 
to each well. After 30 minutes of incubation, the cells were washed with Dulbecco’s 
phosphate-buffered saline (DPBS; WorldWide Life Sciences, 61211088). DMEM with 
gentamicin was added to remove extracellular bacteria and the cells were incubated. Two 
hours after infection, the cells were lysed with sterile deionized water. The lysate was 
plated on Luria Broth (LB) plates and was used to measure fluorescence at λex=494 nm and 
λem= 521 nm in a 96-well plate. The input fluorescence was also measured. After plating, 
the LB plates were incubated for ~2 days and colonies were counted using an aCOLyte 3 
plate reader (Synbiosis) to determine intracellular percent input.  
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Results and Discussion 
 
To begin establishing the effects of propionate on macrophages, I first investigated 
how phagocytosis by macrophages was affected by propionate in the absence of infection 
using the Vybrant Phagocytosis Assay Kit (V-6694). Figure 1 shows the results of a 
phagocytosis assay with 5 replicates for each condition. Macrophages that were cultured 
for 18 hours with 0.1 mM, but not 1.0 mM exhibited an elevated fluorescence. This 
observation suggests that macrophages can sense and respond to propionate by potentially 
altering their phagocytic activities. These results also suggest that macrophages may 




Figure 1. Phagocytic activity of macrophages when treated with propionate for 18 hours. 
The experiment was conducted in a 96 well plate with five replicates per treatment 
condition. The error bars represent standard deviations. 
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After determining the effect of propionate on macrophage phagocytosis, a 
gentamicin protection assay was conducted to determine intracellular survival of L. 
monocytogenes in macrophages during infection. Macrophages and L. monocytogenes 
were cultured, with or without propionate, for 15 hours in a 96 well plate. The results in 
Figure 2 indicate that in both aerobic and anaerobic conditions, macrophages treated with 
1 mM propionate had a decreased intracellular CFU. These results suggest that 
supplementing macrophages with propionate can impact their bactericidal activity and 
result in reduced intracellular L. monocytogenes survival. However, in this experiment, 
treatment of L. monocytogenes with 25 mM propionate did not affect intracellular CFU.  
There was also no significant difference between the treatment in which both L. 
monocytogenes and macrophages were cultured in propionate and the treatment in which 
just macrophages were cultured with propionate. This lack of significance suggests that 
when macrophages are cultured in propionate, infection with L. monocytogenes 
supplemented with propionate did not alter intracellular survival. Based on the effect of 
propionate determined in this experiment, I decided to further investigate and characterize 








Figure 2. Intracellular survival of L. monocytogenes when macrophages and/or L. 
monocytogenes were cultured in 1 mM, or 25 mM propionate, respectively. Propionate 
treatment was for 15 hours and the experiment was performed in a 96 well plate with four 
replicates for each treatment. Error bars represent standard deviations. 
 
 To further characterize the effects of propionate on macrophages and L. 
monocytogenes interactions, a similar gentamicin protection assay was conducted with 
altered treatment durations. In this experiment, macrophages and L. monocytogenes were 
cultured overnight and treated with propionate for three hours. Compared to the experiment 
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in Figure 2, the experiment in Figure 3 had a shorter treatment period and propionate was 
not removed from macrophages until after the 30 minute infection period. Figure 3 shows 
that in aerobic, but not anaerobic conditions, treatment of macrophages or L. 
monocytogenes with propionate resulted in decreased intracellular CFU. Therefore, 
propionate supplementation reduced the percent survival of aerobically grown L. 
monocytogenes. Additionally, when macrophages and L. monocytogenes were both treated 
with propionate, there was a reduced intracellular survival compared to when only 
macrophages were treated with propionate. However, there was no significant difference 
in the resulting intracellular survival between L. monocytogenes treated with propionate 
alone and L. monocytogenes and macrophages both treated with propionate.  
Compared to the results shown in Figure 2, Figure 3 shows a similar trend in 
reduced L. monocytogenes survival when macrophages are treated with propionate. 
However, in Figure 3, there was no significant difference between treatment conditions 
when L. monocytogenes were cultured anaerobically. Therefore, it seems that propionate 
treatment for three hours is not enough to cause a difference in bactericidal activity of 
macrophages or virulence of L. monocytogenes when cultured anaerobically. Additionally, 
Figure 3 indicates that a three hour propionate treatment of aerobically cultured L. 
monocytogenes can reduce intracellular survival while Figure 2 shows that a 15 hour 
propionate treatment of aerobically cultured L. monocytogenes does not significantly 
reduce intracellular survival. The differences in results between Figures 2 and 3 are likely 
caused by the difference in duration of propionate treatment and the presence or absence 
of propionate during infection. 





Figure 3. Intracellular survival of L. monocytogenes when macrophages and/or L. 
monocytogenes were cultured in 1 mM, or 25 mM propionate, respectively. The 
pretreatment of propionate was for three hours, and the experiment was conducted in a 96 
well plate with four replicates for each treatment. Error bars represent standard 
deviations. 
 
Once the effects of propionate were established under varying treatment lengths, I 
aimed to determine how these effects may be mediated in macrophages. In order to obtain 
these results, a L. monocytogenes mutant deficient in the hly gene was used in addition to 
the wild type (WT). The lack of the hly gene results in the absence of LLO, a protein which 
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allows L. monocytogenes to escape the phagosome. These L. monocytogenes were cultured 
overnight in aerobic conditions, while macrophages were cultured overnight and treated 
with propionate for three hours prior to infection. Figure 4 shows the resulting intracellular 
CFU, in which propionate treatment of macrophages did not significantly impact the 
percent input CFU of WT L. monocytogenes. However, propionate treatment of 
macrophages resulted in a reduced percent input CFU of LLO deficient mutant. 
Interestingly, LLO deficient L. monocytogenes survived similarly to the WT despite its 
inability to escape the phagosome. One might expect that LLO deficient L. monocytogenes 
to have reduced intracellular survival. A possible explanation for the similarity in 
intracellular survival of WT and LLO deficient L. monocytogenes is that a difference in 
intracellular survival may not be present only two hours after infection. A change in 
intracellular survival may require a longer infection period. Figure 4 also shows results 
that do not perfectly match the findings of previous experiments, including the absence of 
a significant difference between macrophages treated with and without propionate for an 
infection with WT L. monocytogenes. One possible explanation for this dissimilarity is that 
the gentamicin protection assays for Figure 4 were conducted in a 24 well plate, whereas 
previous experiments had been conducted in 96 well plates. While there is no apparent 
difference in percent survival of WT and LLO deficient L. monocytogenes, the difference 
when macrophages are treated with propionate and infected with LLO deficient L. 
monocytogenes is significant. 
The difference between the effects of propionate in survival of WT and hly mutants 
indicates that these effects may be mediated through altered activity in the phagosome. The 
reduced survival of the hly mutant indicates that propionate can increase bactericidal 
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activity in the phagosome. However, there was a possibility that these results could have 
been due to a difference in phagocytosis of WT and LLO deficient L. monocytogenes. To 
determine whether the effects of propionate are mediated through phagocytic activity, 




Figure 4. Intracellular survival of WT and LLO deficient L. monocytogenes when 
macrophages are treated with propionate for three hours. The experiment was conducted 
in a 24 well plate with three replicates per treatment condition. The graph shows an 
average of three separate experiments and the error bars represent standard errors of the 
mean. 
 
  Phagocytic activity was measured to determine whether the effects of propionate 
were mediated through changes in phagocytosis rates of macrophages. L. monocytogenes 
was labelled with CFSE to determine how much bacteria were present in macrophages 
under various experimental conditions. One of these experimental conditions was the 
presence of LPS and IFN-γ during the growth of overnight macrophage cultures. These 
molecules were used to activate macrophages and simulate physiological conditions in 
which macrophages are already active.  Figure 5 indicates that treatment of macrophages 
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with propionate or activating molecules did not significantly impact phagocytosis of WT 
L. monocytogenes. Similarly, under either aerobic or anaerobic conditions, phagocytosis of 
hly mutants was not significantly impacted by the presence of propionate or activating 
molecules. However, there was a significant difference in intracellular fluorescence in 
macrophages infected by aerobically or anaerobically cultured hly mutants. These results 
suggest that hly mutants may differentially alter the phagocytosis process depending on 
whether they are grown aerobically or anaerobically. Overall, the results from Figure 5 
demonstrate that the reduction in intracellular survival caused by propionate treatment of 
macrophages is not due to a reduction in phagocytic activity. Interestingly, most propionate 
treatments actually caused a slightly higher intracellular fluorescence compared to the 
treatment without propionate under the same conditions. Therefore, it is likely that the 









Figure 5. Intracellular fluorescence of wild type and hly L. monocytogenes when 
macrophages were treated for 3 hours prior to infection. Macrophages were also cultured 
for 18 hours overnight with LPS and IFN-γ. The experiment was conducted in a 24 well 
plate with three replicates per treatment condition. The graph shows an average of three 
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Conclusion 
 This research project aimed to provide a better understanding of how propionate 
may affect L. monocytogenes infection outcome in macrophages. The effects of propionate 
on intracellular survival depend highly on experimental conditions, such as the length of 
propionate exposure. Using a mutant of L. monocytogenes that cannot escape the 
phagosome, it seems that propionate may alter activity in the phagosome. The lack of a 
significant difference in phagocytic activity supports the conclusion that propionate 
impacts activity beyond phagocytosis.  
 In the future, more research is needed to determine how propionate mediates its 
effects on macrophages and L. monocytogenes in the phagosome. One way to study the 
effect of propionate on macrophage bactericidal activity is through quantifying reactive 
oxygen species (ROS) produced in response to propionate supplementation. The results of 
this future research will determine if the reduced intracellular survival caused by 
propionate supplementation is due to a reduction in ROS. Additionally, recent and future 
work has focused on how propionate impacts macrophage cell motility. If propionate 
impacts cell motility, macrophages may be able migrate differently to L. monocytogenes 
and affect infection outcome.  
 While more research is needed to determine how propionate supplementation 
causes reduced intracellular survival under certain circumstances, this research and related 
future research has relevant clinical significance. With growing antibiotic resistance, a 
better understanding of pathogenic responses to environmental factors is needed. 
Ultimately, these research findings enhance our understanding of how pathogens respond 
and adapt to environmental factors that can influence host-pathogen interactions and alter 
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infection outcomes. This knowledge will allow us to better protect individuals at high risk 
for deadly infections and promote human health. 
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